Back to Stakeholders
Categories

1 domain / 2 areas / 3 specializations

Research, Drug Development & Manufacturing
Clinical Trial InfrastructureCROs & Full-Service Trial DeliveryPatient Recruitment & Retention PlatformsSite Networks & SMOs
Research, Drug Development & Manufacturing

Altasciences

Data updated

Laval facility - 575 Armand-Frappier Blvd., Laval, QC H7V 4B3, CanadaMontreal facility - 1200 Beaumont Avenue, Montreal, QC H3P 3P1, CanadaKansas City facility - 10103 Metcalf Avenue, Overland Park, KS 66212, United StatesSeattle facility - 6605 Merrill Creek Parkway, Everett, WA 98203, United StatesPhiladelphia facility - Harleysville, PA 19438 (city-level coordinate), United StatesLos Angeles facility - 5630 Cerritos Avenue, Cypress, CA 90630, United StatesScranton facility - 130 Discovery Drive, Scott Township, PA 18447, United StatesColumbia facility - Auxvasse, MO 65231 (city-level coordinate), United StatesSacramento facility - Sacramento, CA (city-level coordinate), United States

Early-phase CRO with a dedicated psychedelic clinical trials offering, set-and-setting units, controlled-substance handling, facilitator oversight, and participant recruitment infrastructure.

Clinical Trial Infrastructure Snapshot

CROs & Full-Service Trial Delivery

Service Model

Full-Service CRO

Service Coverage

2 countries

Psychedelic Experience

Verified Psychedelic Trial Experience

Last Source Check

Jun 18, 2026

Public Sources

5

Lifecycle Coverage

Feasibility & Protocol DesignStudy Startup & Site ActivationRecruitment & RetentionTrial Operations & MonitoringData Management & BiostatisticsSafety Operations / Pharmacovigilance

Service Coverage Countries

CanadaUnited States

Phase Coverage

Pre-Clinical / IND-Enabling SupportPhase IPhase II

Capabilities

Site Network AccessPatient Recruitment MediaBiometrics / StatisticsSafety / Pharmacovigilance

Research Update

Public-source profile available

Last checked Jun 18, 2026 across 5 sources.

Search Finding

Dedicated psychedelic clinical trial offering with set-and-setting units, facilitator oversight, Schedule I readiness, and large volunteer database.

Primary Service Link

Service Notes

Use as a source-backed early-phase psychedelic CRO profile. Coverage should remain North America/verified facilities unless future sources name more psychedelic units.

Linked Stakeholders

No linked stakeholders yet.

Linked Trials

Pharmacokinetics, Safety, and Tolerability of Intramuscular 5-MeO-DMT in Healthy Volunteers

Completed

An Evaluation of Psilocybin’s Effect on Cardiac Repolarization

Completed

Source Evidence

Altasciences — Psychedelic Clinical Trials

https://www.altasciences.com/clinical-research-services/psychedelic-clinical-trials

Altasciences — Clinical Research Services

https://www.altasciences.com/clinical-research-services

Altasciences — CNS Clinical Trials

https://www.altasciences.com/clinical-research-services/cns-clinical-trials

Altasciences - Facilities

https://www.altasciences.com/facilities

Altasciences - Contact Us

https://www.altasciences.com/contact-us

Quick Facts

HQ
Laval facility - 575 Armand-Frappier Blvd., Laval, QC H7V 4B3, Canada
Website
Visit